NCT02199678View on ClinicalTrials.gov

A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Pain
Interventions
DRUG

Placebo

placebo

DRUG

ketamine 25 mg

ketamine

DRUG

ketamine 35 mg

ketamine

DRUG

ketamine 50 mg

ketamine

Trial Locations (2)

84106

Prahealthsciences, Salt Lake City

91105

Lotus Clinical Research, LLC, Pasadena

Sponsors
All Listed Sponsors
collaborator

iX Biopharma Ltd.

OTHER

lead

Lotus Clinical Research, LLC

OTHER

NCT02199678 - A Study to Assess the Analgesic Properties of a Sublingual Wafer Formulation of Ketamine Following Third Molar Extraction | Biotech Hunter | Biotech Hunter